GAS5 and breast carcinoma: Another report showed that GAS5 manifested tumor suppressor effects and induced chemosensitivity to breast cancer cells by indirectly targeting the miR-378-5p/SUFU signaling pathway [87], as well as by competitively binding miR-196a-5p [87].